Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Switzerland
Page logo
Our Company

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

New Brunswick, NJ (May 13, 2021 - REVISED) -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference on Tuesday, June 8th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 8:50 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.
###

  • Press Contacts:
    Christina Chan
    (732) 524-6297

    Investor Contacts:
    Christopher DelOrefice
    (732) 524-2955

    Jennifer McIntyre
    (732) 524-3922
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue